AI is a tool. The business is the point. We work where it earns its place in the operation, and we stay out of where it doesn't.
The market sells novelty. Operations need durability. The right test isn't what a model can do — it's what changes on Monday morning, and whether the change still holds a quarter from now.
We measure in the language the business already uses: throughput, cycle time, margin, decision latency, hours back. If an intervention can't be defended in those terms, it isn't worth running. We pick the smallest change that moves the number, and we leave the rest alone.
We've run operations. We read a business by its constraints, not its slide deck.
No logo walls, no manufactured case studies, no thought-leadership theatre.
Polite, but unsoftened. The diagnosis we owe you is the one we'd give a partner.
We name the metric we expect to move before we start. If it doesn't move, we don't pretend.
These aren't ideas borrowed from a framework. They came from years inside operations, where the cost of being wrong shows up in throughput, payroll, and the next quarter. A few things keep proving themselves — and shape every engagement we take on.
The smallest change that moves the number is almost always the right one. Scope grows the risk faster than the result.
Activity isn't outcome. We name the number up front and judge the work against it, not against effort.
Intervention has a cost. If a process already earns its keep, the most senior move is to walk past it.
We work the way operators want to be worked with. No surprises in scope, no surprises in staffing, no surprises in the bill.
Before any scope, we tell you whether the leverage is real. Sometimes the answer is don't.
NDA-friendly. Your name, your data, your numbers stay yours. We don't trade on them.
No bait-and-switch staffing, no junior layers between you and the diagnosis.
Scoped engagements with written exit criteria. No open-ended retainers.
If AI isn't the right lever, we'll tell you.